A Multicenter, Open Phase IIb Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Colorectal Cancer

NCT06838546 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Colorectal Cancer

Interventions

DRUG: B1962

Sponsor

Tasly Biopharmaceuticals Co., Ltd.

Collaborators

[object Object]